Search hospitals > Pennsylvania > Philadelphia
Temple University Hospital
Claim this profilePhiladelphia, Pennsylvania 19140
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Coronavirus
Conducts research for Fibrosis
Conducts research for Chronic Obstructive Pulmonary Disease
392 reported clinical trials
57 medical researchers
Summary
Temple University Hospital is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Coronavirus, Fibrosis, Chronic Obstructive Pulmonary Disease and other specialties. Temple University Hospital is involved with conducting 392 clinical trials across 781 conditions. There are 57 research doctors associated with this hospital, such as Gerard J Criner, Hossein Borghaei, Thomas Galloway, MD, and Nina T Gentile, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Gerard J CrinerTemple University1 year of reported clinical research
Studies Fibrosis
Studies Pulmonary Fibrosis
32 reported clinical trials
45 drugs studied
Hossein BorghaeiFox Chase Cancer Center5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
21 drugs studied
Thomas Galloway, MDFox Chase Cancer Center3 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Cancer
9 reported clinical trials
15 drugs studied
Nina T Gentile, MDTemple University Hospital1 year of reported clinical research
Studies Stroke
Studies Coronavirus
9 reported clinical trials
14 drugs studied
Clinical Trials running at Temple University Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Squamous Cell Carcinoma
Cancer
Deep Vein Thrombosis
Stroke
Oropharyngeal Carcinoma
Chronic Obstructive Pulmonary Disease
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Temple University Hospital?
Temple University Hospital is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Coronavirus, Fibrosis, Chronic Obstructive Pulmonary Disease and other specialties. Temple University Hospital is involved with conducting 392 clinical trials across 781 conditions. There are 57 research doctors associated with this hospital, such as Gerard J Criner, Hossein Borghaei, Thomas Galloway, MD, and Nina T Gentile, MD.
Where is Temple University Hospital located?
**Temple University Hospital**
- **Address:** 3401 North Broad Street, Philadelphia, PA 19140
- **Description:** A major teaching hospital and Level 1 Trauma Center within the Temple University Health System.
Who should I call to ask about financial aid or insurance network?
**Temple University Hospital Contact Information:**
- **Risk & Insurance Department:** For claims, insurance coverage verification, and claims processing, call (215) 204-5217 or email kkurien@temple.edu.
- **TU Global Assistance Provider:** For international travel planning assistance, contact +1-267-855-1884.
- **Financial Services Department:** For financial assistance and charity care, visit or contact the Financial Services departments at Temple Health hospitals. Financial counselors are available to assist uninsured individuals or those unable to afford care.
What insurance does Temple University Hospital accept?
Temple University Hospital accepts most area insurance plans. Patients are advised to confirm with the Financial Assistance teams regarding the acceptance of specific insurance plans. Pre-approval for medical procedures and hospitalization is required, which must be obtained by the physician from the insurance company.
What awards or recognition has Temple University Hospital received?
Temple University Hospital, located in Philadelphia, Pennsylvania, is celebrated for its exceptional care, as acknowledged by Healthgradesâ„¢. It is part of Temple Health, which is renowned for its commitment to clinical innovation, pioneering research, and world-class education. This institution excels in transforming scientific discoveries into practical therapies.